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rearranged k genes (Staudt and Lenardo, 1991). How-
ever, gene-targeted mutational analyses have shown
that deletion of the iEk/MAR results in a major impair-
ment in k gene rearrangement with no effect on re-
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reporter gene studies have shown that 39Ek becomesResearch Laboratories
active during the late pro-B to pre-B cell stages andThe Children's Hospital
becomes even more active upon B cell activation (MeyerBoston, Massachusetts 02115
et al., 1996). The 39Ek has been implicated as necessary
for optimal expression of rearranged k genes, as addi-
tion of the 39Ek to rearranged k transgenes that includedSummary
the iEk/MAR resulted in enhanced expression levels,
which were sufficient to block endogenous k gene re-Transgenic studies have led to the conclusion that the
arrangement (Meyer et al., 1990; Blasquez et al., 1992).39Ek enhancer functions to suppress k variable region
Gene-targeted mutation studies further showed that de-gene assembly in T lineage cells and in progenitor B
letion of the 39Ek resulted in a substantial impairment ofcells and have also implicated 39Ek asa critical element
k gene expression in resting B cells, with a less dramaticin promoting somatic hypermutation of k variable re-
effect on k gene rearrangement (Gorman et al., 1996).gion genes. To assess the role of the endogenous 39Ek, Together, these types of studies suggested that the 39Ekwe assayed these processes in mice homozygous for
and the iEk/MAR have overlapping activities, with eachmutations in which the 39Ek sequences were deleted
having a more central role in certain processes.by the loxP/Cre method (39EkD/D mice). In contrast to
Recent transgenic studies have led to the surprisingtransgenic findings, we found that deletion of the en-
conclusion that the 39Ek sequence may play a negativedogenous 39Ek did not deregulate k gene rearrange- role in regulating k gene rearrangement (Hiramatsu etment in T lineage cells or in pro-B cells. Furthermore,
al., 1995; Hayashi et al., 1997). Thus, mice that carryimmunization of the39EkD/D mice led to the generation transgenic k recombination substrates with only the in-of specific antibodies with mutation patterns typical of
tronic k enhancer and no 39k enhancer (or a 39Ek thataffinity maturation, showing that there is no absolute
lacked the binding site for the transcription factor PU.1)requirement for the 39Ek with respect to somatic muta- were found to rearrange the transgenic Vk genes in bothtion of endogenous k genes.
B and T lineage cells, leading to the conclusion that the
39Ek serves as a negative regulator of k gene re-Introduction arrangement in developing T cells (Hiramatsu et al.,
1995). Rearrangement of the majority of endogenous VkImmunoglobulin heavy and light chain variable region genes in normal mice occurs at the pre-B cell stage of
genes and T cell receptor variable region genes are development, subsequent to Ig HC gene rearrangement
assembled, respectively, in differentiating B and T lin- (reviewed by Lansford et al., 1996). However, transgenic
eage cells from component V, D, and J segments (re- k LC gene minilocus recombination substrates that
viewed by Okada and Alt, 1994). Immunoglobulin k light lacked 39Ek were found to undergo rearrangement at
chain (LC) variable region genes are assembled subse- the early pro-B to late pro-B cell stage, simultaneous
quent to Ig heavy chain (HC) variable region genes dur- with HC gene rearrangement (Hiramatsu et al., 1995).
ing B cell differentiation and are not assembled in T Furthermore, nucleotide sequence analysis of the Vk-Jk
lineage cells (reviewed by Lansford et al., 1996; Gorman joins in these substrates revealed a high frequency of
and Alt, 1998). As the V(D)J recombination process is N insertions,confirming that these rearrangements must
effected by a common enzymatic machinery, this lin- have occurred at the pro-B cell stage, in which terminal
eage-specific rearrangement is mediated, at least in deoxynucleotidyl transferase (TdT) activity is high. In
part, by cis-acting regulatory elements, such as tran- addition, the pro-B/pre-B rearrangement specificity was
scriptional enhancers, that modulate accessibility of the also lost when the 8.4 kb region between Ck and 39Ek
substrate variable region gene segments (reviewed by was deleted, suggesting the existence of an additional
Sleckman et al., 1996). The Igk locus includes two known suppressive element that regulates pro-B/pre-B re-
B cell±specific transcriptional enhancer elements: the arrangement specificity (Hiramatsu et al., 1995; Hayashi
intronic k enhancer/matrix attachment region (iEk/MAR) et al., 1997).
located in the Jk-Ck intron and the 39 k-enhancer (39Ek) After assembly and expression of functional Ig HC
located 8 kb downstream of the Ck gene (Emorine et al., and LC genes, B lineage cells mature in the bone marrow
1983; Picard and Schaffner, 1984; Queen and Stafford, and then migrate into the periphery where, upon interac-
1984; Meyer and Neuberger, 1989). tion with cognate antigens, they can undergo further
Transfection and transgenic studies have shown that maturation (reviewed by Milstein and Neuberger, 1996).
both the iEk/MAR and the 39Ek promote transcription of Such activation of the B cells results in the formation
of germinal centers and the activation of a somatic hy-
permutation process that introduces mutations into the*To whom correspondence should be addressed (e-mail: alt@
rascal.med.harvard.edu). HC and LC variable region genes, allowing further affinity
Immunity
744
maturation of the antibody response (Liu et al., 1989;
Berek et al., 1991; Jacob and Kelsoe, 1992; MacLennan,
1994). Studies employing rearranged k LC transgenes
have suggested that both the 39Ek and the iEk/MAR are
critical for allowing the somatic hypermutation process
to act on linked Vk genes (Sharpe et al., 1991; Betz et al.,
1994). Deletion of either enhancer from the constructs
resulted in a severe drop of mutation frequency. How-
ever, the extent of mutation in constructs lacking the
39Ek appeared linked to the level of k transgene expres-
sion in mature and activated B cells (Meyer et al., 1996;
Goyenechea et al., 1997). Because such expression var-
ied with respect to different integration sites of the
transgene, it was difficult to directly assess the function
of the 39Ek in promoting k expression versus specifically
recruiting the somatic mutation machinery.
To date, all information regarding potential functions
of the 39Ek and the iEk with respect to lineage and stage
specificity and somatic mutation has come from assays
of transfected cell lines and mice with transgenes con-
taining rearranged or unrearranged k miniloci under the
control of one, the other, or both enhancers. However,
the role of these enhancers in regulating such functions
has not been studied in the context of the endogenous
locus. Recently, we generated two mutations of the
mouse germline in which the 39Ek was replaced by either
a neor gene (39EkN) or by a loxP sequence (39EkD) (Gor-
man et al., 1996). Mice homozygous for the 39EkD muta-
tion (39EkD/D) had decreased numbers of splenic B cells
and reduced levels of surface k expression. In addition,
k to l ratios were severely reduced to 2:1 as compared
Figure 1. Analysis of k Gene Rearrangement in Thymic and Splenicto 20:1 in wild-type (wt) littermates. The homozygous
T Cells of 39EkD/D and Wt Littermates
39EkN mutation (39EkN/N) resulted in a similar but more (A) Schematic map showing the structure of the k locus and descrip-
pronounced phenotype (with k to l ratios of 1:1). One tion of k-specific PCR primer locations and expected products.
possible interpretation of this effect is that the ex- (B and C) PCR assay for k gene rearrangements in D/D and control
(1/1) DNA samples. Vk-Jk junctions were amplified in 30 cycles withpressed neor cassette somehow neutralizes the activi-
a degenerate Vk primer and a specific Jk2 primer (as shown in [A])ties of a complementary cis-acting element such as the
from genomic DNA (gDNA) samples generated from total spleeniEk/MAR. cells and FACS-sorted CD31 splenic and thymic T cells of D/D4 (B)
Here, we have utilized the 39EkD/D mutant mice to or D/D23 and D/D24 (C) mice and of 1/15 (B) and 1/117 (C) wt
directly assess putative 39Ek functions with respect to mice. In both panels, GADPH genes were amplified in 22 cycles
stage and lineage specificity and with respect to pro- with specific primers using the same gDNA samples. PCR Vk-Jk1
and Vk-Jk2 rearrangement products were detectedwith a Jk probe asmoting somatic hypermutation following specific immu-
described in Experimental Procedures and GADPH products werenization.
detected with a GADPH-specific cDNA probe. In (B), lanes 1±5 and
6±9 contain PCR products obtained with 10-fold serial dilutions of
splenic T cell gDNA derived from, respectively, mouse D/D4 and
Results 1/15, starting at 1 mg. Lanes 10 and 21 are control lanes obtained
with, respectively, 2 mg of 1/15 splenic gDNA and water. Lanes
11±15 and 16±20 contain PCR products obtained with 10-fold serialB/T Specificity of k Gene Assembly Is Retained
dilutions of total splenic gDNA derived from, respectively, D/D4 andin 39Ek Mutant Mice
1/15 mice, starting at 1 mg. In (C), lanes 1±5 contain PCR products
To test whether the endogenous 39Ek is required for obtained with 10-fold serial dilutions of splenic gDNA derived from
suppression of k gene rearrangement in T lineage cells, the D/D23 mouse (starting at 500 ng), lanes 6±7 contain PCR prod-
we assayed genomic DNA (gDNA) from purified thymo- ucts obtained with 500 ng and 100 ng of thymic D/D23 mouse gDNA,
lanes 8±9 contain PCR products obtained with 500 ng and 100 ngcytes and peripheral T cells of wt and 39EkD/D mice for
of thymic 1/117 gDNA, lanes 10±11 contain PCR products obtainedthe presence of Vk-Jk rearrangements. For this purpose,
with 500 ng and 100 ng of thymic D/D24 mouse gDNA, and lanes
we utilized a polymerase chain reaction (PCR) assay 12±15 contain splenic D/D23 mouse gDNA in the same dilution range
that employed a degenerate Vk primer and a Jk2-specific as in lane 1±5 with the addition of thymic D/D23 mouse gDNA (500
primer (Figure 1A) (Schlissel and Baltimore, 1989). We ng). Lanes 16 and 17 are, respectively, splenic D/D26 gDNA and a
water control.first tested gDNA samples isolated from splenic T cells
and total spleen cells with amounts ranging from 0.1 to
1000 ng per reaction. While total spleen cell DNA from as 1 ng (Figure 1B lanes 11±20), no k rearrangement
wt and 39EkD/D mice generated readily visible k re- products were detected with even the highest amount
of purified splenic T cell gDNA from either wt or 39EkD/Darrangement PCR products with gDNA amounts as low
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Figure 2. Analysis of k Gene Rearrangement in Pro- and Pre-B Cells
of 39EkD/D and Wt Littermates
Vk-Jk junctions were amplified in 30 cycles with a degenerate Vk
primer and a specific Jk2 primer using genomic DNA (gDNA) samples
derived from FACS-sorted pro-B and pre-B cells from bone marrow
of mouse D/D8 and mouse 1/17. GADPH genes were amplified in
22 cycles with specific primers using the same gDNA samples.
Lanes 1±5 and 6±10 contain PCR products obtained with 10-fold
serial dilutions of pro-B cell gDNA derived from, respectively, mouse
D/D8 and mouse 1/17. Lanes 11±15 and 16±20 contain PCR prod-
ucts obtained with 10-fold serial dilutions of pre-B cell gDNA derived
from, respectively, mouse D/D8 and mouse 1/17, and lane 21 is a
control PCR that contains no gDNA.
mice (Figure 1B, lanes 1±9). Next, we amplified k re-
Figure 3. Nucleotide Sequences of Vk-Jk Junctions Amplified fromarrangements from purified thymic (CD31) T cell gDNA
CD431/IgM2 and CD432/IgM2 Bone Marrow B Cells of 39EkD/D Micewith the same set of primers; again, no Vk-Jk1/2 joins CD431/IgM2 and CD432/IgM2 bone marrow cells were isolated from
were detected at any concentration of either wt or mu- three mutant 39EkD/D mice, and Vk-Jk junctions were amplified with
tant thymocyte gDNA (Figure 1C, lanes 6±11). To further either a VkOx (mouse 45 and 26) or degenerate Vk primer (mouse
test the detection sensitivity for k rearrangements, vary- 45 and 28) together with a Jk2 and/or Jk5 primer. Sequences ob-
tained with the VkOx-specific primer are aligned with the germlineing amounts of spleen cell gDNA were mixed with 500
VkOx1 sequence, and those obtained with the degenerate Vk primerng of purified thymocyte gDNA and then subjected to
are each aligned with the most homologous Vk gene to that genethe amplification procedure. Similar levels of k re-
found in the EMBL database (indicated with their accession
arrangements were detectable with and without the ad- number).
dition of thymocyte gDNA, indicating that the thymocyte
gDNA was in no way inhibitory to the PCR process
derived k rearrangements from mutant B lineage cells
(Figure 1C, compare lanes 1±5 to lanes 12±15). We con-
demonstrated the absence of any apparent N region
clude that mice homozygous for a germline deletion
insertions (Figure 3). Because it is sometimes difficult
of 39Ek show no evidence for deregulation of Vk to Jk to find the correct Vk germline counterpart sequence forrecombination in T lineage cells. isolated Vk-Jk rearrangements, we also determined the
nucleotide sequence of a set of VkOx family specific kStage Specificity of k Gene Recombination rearrangements, where the contributing Vk gene seg-Is Maintained in 39Ek Mutant Mice ment could be identified with certainty. For this purpose,
To evaluate the putative suppressive role of the 39Ek VkOx rearrangements were amplified from pro-B and
region on the rearrangement of endogenous k genes at pre-B cells using a VkOx family specific primer together
the pro-B/pre-B stage of development, we assayed for with a Jk2 or Jk5 primer. All VkOx-Jk junctionalsequences
rearrangements of the k locus in pro-B cells of 39EkD/D obtained from the mutant B cells were aligned with the
mice. For this purpose, pro-B and pre-B cells were puri- germline VkOx1 sequence; again we observed no in-
fied by FACS sorting of, respectively, B2201, CD431, creased N region additions in the VkOx rearrangements
IgM2 and B2201, CD432, IgM2 bone marrow cells, from isolated from the39EkD/D pro-Bor pre-B cell populations
39EkD/D and wt littermates. Vk-Jk rearrangements were (Figure 3). Furthermore, we confirmed this result via
then amplified from gDNA derived from both purified analyses of VkOx-Jk5 transcripts isolated from PNAhigh
populations by PCR with the degenerate Vk primer in splenic B cells after immunization with oxazolone (see
combination with a Jk2 (or Jk5) primer. As expected, we below). Together, our findings indicate that deletion of
observed high levels of Vk-Jk rearrangements in DNA 39Ek does not promote premature Vk gene recombination
samples from the pre-B cell fractions of wt and mutant within the endogenous k locus at the pro-B cell stage.
mice (Figure 2, lanes 11±20). However, we found only
low levels of Vk-Jk rearrangements in the pro-B cell DNA Somatic Mutation of k Genes in Mice
samples derived from either wt or mutant mice, and the Lacking the 39Ek
level of the Vk-Jk rearrangements in these samples was The antibody response to the hapten 2-phenyl-5-oxazo-
similar (Figure 2, lanes 1±10). lone (ph-Ox) is characterized by the recurrent expres-
sion of an LC variable region encoded by a VkOx1 joinedNucleotide sequence analysis of pro-B and pre-B cell±
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Table 1. Mutation Frequency and Specificity in VkOx1-Jk5
Transcripts from Oxazolone-Immunized Mice
39Ek D/D
Hotspot Affinity
VkOx-clone # Mut Ser His Tyr
119-a1 5 - N F
119-a20 3 - N F
119-31 2 - N F
119-a33 10 R N F
119-a45 4 - - F
119-30 6 - - -
119-22 6 - - -
103-11 9 - - -
103-31 10 - - -
103-48 0 - - -
103-06 0 - - -
103-34 1 - - -
103-02 2 R - -
103-51 5 ± N F
103-24 4 - Q F
103-54 8 - N F
103-A1 2 - - -
103-A11 11 - Q F
103-A13 8 - Q F
103-A14 1 - - -
103-A15 3 - - F
Wt Littermates
Hotspot Affinity
VkOx-clone # Mut Ser His Tyr
70-18 11 I N F
70-28 13 I N F
70-11 1 - - -
Figure 4. Anti-Oxazolone Antibody Response in 39Ek Mutant Mice 70-37 5 T - -
and Their Wt Littermates 70-21 10 Y - -
70-a16 13 I N FSerum samples were taken before and 7 days after primary immuni-
70-a4 12 I N Fzation (1) and at day 3 after boosting (2), as described in the Experi-
70-a6 12 Y - -mental Procedures. All sera samples were analyzed for Ox-specific
70-A1 8 T - -k-expressing antibodies using oxazolone conjugated to BSA as a
72-2 4 I Q Fcapture agent and anti-k-specific AP-conjugated antibodies for de-
72-10 5 - N Ftection as described in the Experimental Procedures. The k levels
72-55 4 - - -are displayed as absorbance units (OD405) versus a. (A) shows
72-5 2 - - -the Ox-specific k response after primary immunization including
72-4 3 - - -preimmune serum of 39EkD/D mouse 103. (B) shows the Ox-specific
k response after secondary immunization.
Shown is the frequency and nature (e.g., at hotspot or associated
with affinity maturation) of mutations in Vk transcripts derived from
oxaolone-immunized mice: 39Ek D/D mice and wt littermates. VkOx1
transcripts were amplified from B2201/PNAhigh-expressing splenic
B cells and aligned with the published germline VkOx1 sequence.to Jk5 (Kaartinen et al., 1983; Griffiths et al., 1984; Berek
Transcripts were derived from two 39EkD/D mice (respectively, 119and Milstein, 1988). After secondary immunization, Ox-
and 103) and two wt littermates (72 and 70). The total number ofspecific B cells often express VkOx1 LC genes with an mutations are indicated in the first column. Hotspot and affinity
increased number of mutations compared to those seen maturation mutations in codons 31(Ser), 34(His), and 36(Tyr) are
after the primary response, including frequent mutations indicated with one letter amino acid code and hyphens indicate no
replacement mutation in this codon.(His-34 and Tyr-36) that are known to increase binding
affinity (Berek and Milstein, 1987; Alzari et al., 1990;
Rada et al., 1991). In addition, several mutational hot-
spots have been noted (including Ser-26, Ser-28, Ser- splenic B cells, VkOx-Jk5-specific transcripts were am-
plified by RT±PCR, and the sequence of at least 20VkOx-31, Met-33, and Ser-77). To assess the role of 39Ek in
hypermutation of endogenous Vk-Jk rearrangements, we Jk5-cDNA clones per mouse was determined.
We analyzed two separate 39EkD/D mice (103 and 119).analyzed the VkOx1 response from 39EkD/D and wt lit-
termates following primary and secondary immunization Both responded to ph-Ox immunization with antigen-
specific k antibodies following primary and secondarywith ph-Ox-chicken-gamma-globulin (CGG). Relative
serum anti-Ox-specific k antibody levels were estimated immunization; however, the specific antibody levels in
the 39EkD/D mice were lower than those of wt miceby ELISA at day 0 and day 7 of the primary immuniza-
tion and 3 days after boosting. In addition, 3 days after (Figures 4A and 4B). Although both wt and mutant
CD45R(B220)1PNAhigh B cells expressed a number ofboosting, RNA was prepared from CD45R(B220)1PNAhigh
Reevaluation of the 39Ek Function
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Figure 5. Nucleotide Sequences of Expressed VkOx1-Jk5 Transcripts Generated Following Oxazolone
(A and B) Sequences from 39EkD/D mice (respectively, 103 and 119). All sequences are aligned with the germline sequence of VkOx1 (Kaartinen
et al., 1983). Since we obtained a large number of identical VkOx1-Jk5 transcripts from mouse 119, we sequenced more than 20 clones (38
total) in order to find several different transcripts. Location of Ser231, His-34, and Tyr-36 are indicated above the germline VkOx1 sequence.
Nucleotide identity is indicated by a period and differences are shown explicitly. CDR regions and replacement mutations are underlined.
different VkOx family members, we focused ouranalyses affinity maturation of the mutant B cells. However, the
frequency of the non-antigen-selected Ser-31 mutationon VkOx1-Jk5 transcripts since these have been exten-
sively characterized. VkOx1-Jk5 transcripts derived from appeared lower in VkOx1 transcripts isolated from
39EkD/D mice as compared to those of wt mice (Tablethe 39EkD/D cells of mouse 119, which had a lower Ox-
specific k response, also had a low diversity of VkOx1- 1 and Figure 5), possibly suggesting that antigen-driven
B cell activation and/or somatic mutation is less efficientJk5 transcripts (see Figure 5B legend), while VkOx1-Jk5
transcripts derived from the 39EkD/D cells of mouse 103, in the mutant cells. In any case, these results clearly
demonstrate that the 39Ek is not required for significantwhich had a higher response, were more diverse (Table
1 and Figure 5A). Significantly, transcripts from both somatic mutation levels of endogenous k genes.
mutant mice showed evidence of somatic hypermuta-
tion, with the totalnumber of mutationsper VkOx1 region Discussion
showing a similarly broad range to that of transcripts
from wt mice (Table 1). Most of the VkOx1 transcripts Previous studies have implicated the 39Ek as positively
regulating rearrangement, transcription, and somaticin the 39EkD/D, like those of wt mice, had replacement
mutations in His-34 and Tyr-36 (Figures 5A and 5B), mutation of the k locus in B lineage cells (Meyer et al.,
1990; Staudt and Lenardo, 1991; Blasquez et al., 1992;suggesting an oxazolone-specific response and normal
Immunity
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Meyer et al., 1996). Other studies have concluded that and stage specificity with respect to rearrangement,
although this result could have been due to speciesthis element also suppresses rearrangement of the k
locus in pro-Bcells and in T lineagecells, thereby enforc- differences (Cavelier et al., 1997). In any case, our stud-
ies clearly show that the 39Ek is not required for suppres-ing stage-specific and lineage-specific rearrangement
(Hiramatsu et al., 1995). However, most of these conclu- sion of endogenous k rearrangements in murine T cells
or in pro-B cells.sions were reached by studying transgenic k miniloci.
Recently, we have employed mice harboring germline
deletions of the 39Ek to show that this element plays a
The 39Ek Is Not Required for Somaticsignificant role in positively regulating the rearrangement
Mutation of Endogenous k Genesand expression of the endogenous k locus (Gorman et
Analyses of transgenic Vk constructs have demon-al., 1996). We have now gone on to test directly the
strated that somatic mutation within the constructs wasproposed functions of the 39Ek with respect to lineage-
markedly diminished for those that lacked 39Ek or theand stage-specific suppression of rearrangement and
iEk (Betz et al., 1994). This enhancer dependence ofwith respect to regulation of somatic mutation. In con-
somatic mutation may be linked to enhancement of tran-trast to the conclusions of transgenic studies, we find
scription, as k transgene expression levels have beenthat the 39Ek is not required to maintain tissue- and
correlated with mutation recruitment (Peters and Storb,lineage-specific control of the endogenous k locus. We
1996; Goyenechea et al., 1997). In agreement with thefurther show that the 39Ek is not required for significant
predicitions of transgene studies, the resting B cells ofsomatic mutation of endogenous k variable region genes
39EkD/D mice did have reduced levels of surface k LCin the context of a specific immune response.
expression (Gorman et al., 1996). However, the 39EkD/D
mice, when immunized, generated mutated VkOx1 anti-
bodies with mutational patterns characteristic of affinityThe 39Ek Is Not Required to Maintain Lineage- and
maturation, indicating no absolute defect in either anti-Stage-Specific Rearrangement
gen-specific activation of 39EkD/D B cells or in recruit-of the Endogenous k Locus
ment of the somatic hypermutation machinery to re-Recent studies of transgenic mice that harbored 2±40
arranged k genes lacking the 39Ek. This apparentcopies of a k locus rearrangement substrate led to the
difference in the requirement for 39Ek with respect toconclusion that the 39Ek acts as a suppressor of Vk-Jk
somatic mutation of the endogenous k locus versus thejoining in the context of maintaining B/T-specific and B
transgenic k loci might reflect transgene-related differ-cell differentiation stage±specific k LC rearrangement
ences (as outlined above); for example, there may be(Hiramatsu et al., 1995; Hayashi et al., 1997). However,
uncharacterized endogenous elements, redundant inwe find no evidence for any deregulation of the k gene
activity to the 39Ek with respect to somatic mutation,rearrangement process in either of these contexts in
that were missing from the transgenes. Moreover, themice that lack the endogenous 39Ek region. In combina-
endogenously derived sequences that we character-tion with the finding that deletion of the 39Ek resulted in
ized, unlike passenger transgene sequences, woulda lower level of k gene rearrangement in l-expressing
have been molded by substantial selection during theB cells (Gorman et al., 1996), our current study demon-
immune response. In this context, we do note that muta-strates that this enhancer functions primarily as a posi-
tion frequency of the strong hotspot mutation (Ser-31)tive regulator of rearrangement and has no suppressive
in 39EkD/D B cells potentially was decreased in 39EkDfunction that is unmasked by its deletion.
loci, suggesting that the total k mutational responseThe discrepancy between our results and those of the
may be less efficient in the absence of the 39Ek.prior transgenic studies could be explained by a number
of potential difficulties known to be inherent to the
transgenic construct approach, including potential ab-
Experimental Procedures
sence of additional endogenous regulatory elements (for
example, suppressive elements) in the transgenes. In Mice and Immunizations
The mutant mice used in this study harbor a homozygous deletionaddition, Vk regions, Jk regions, promoter, and enhancer
of the 39 Ig k LC enhancer (39Ek), by replacing this element withelements generally are not organized within transgenic
either a loxP sequence (39EkD) or a neomycin resistance (neor) genearrays in the same fashion as in the endogenous locus.
(39EkN) and have been described in a former study (Gorman etIn particular, promoters may lie closer to enhancers than al., 1996). Mutant mice and wt littermates were immunized with an
in the endogenous locus, and the linear organization intraperitoneal injection of 80 mg of alum-precipitated phOx-CGG
of elements may be different in transgenic loci due to (kind gift from G. Kelsoe) and boosted 3 or 7 weeks later with an
injection of 80 mg of soluble phOx-CGG. Spleens were removed 3tandem transgene integration. Such alterations in nor-
days after boosting and serum samples were taken before and 7mal organization could promote functions for elements
days after immunization and 3 days after the boost was given.that may not reflect normal endogenous functions. For
example, deregulated transgene expression might be
promoted by placing a Vk gene promoter close to the Serological Assays
Total k and l chainswere detected by ELISA as described previouslyiEk in a tandem array, and such deregulated expression
(Burstein et al., 1991). Oxazolone-specific k and l antibodies weremay be disrupted by including another specific regula-
detected by an ELISA using Ox-BSA-coated plates (kind gift fromtory sequence (e.g., 39Ek) in between. In this regard, G. Kelsoe) and either anti-k- or anti-l-specific AP-conjugated anti-
different transgenes have given different results. For bodies for detection (Sharpe et al., 1990). All sera samples were
example, a human transgenic k rearrangement con- analyzed in duplicate wells in 1:3 serial dilutions ranging from 1:100
to 1:72,900.struct which lacked the39Ek showed appropriate lineage
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and FITC-conjugated anti-k chain, catalog number 1055±02 (South- Received December 12, 1997; May 27, 1998.
ern Biotechnology Associates). The following Pharmingen rat anti-
mouse antibodies were used: PE- or FITC-conjugated anti-k chain
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